STOCK TITAN

[Form 4] RESEARCH SOLUTIONS INC Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Research Solutions (RSSS) director Merrill A. McPeak exercised stock options and acquired shares on June 18, 2025. Key transaction details:

  • Exercised 75,000 stock options at a strike price of $1.10 per share
  • Following the transaction, McPeak directly owns 409,608 shares
  • The exercised options were set to expire on June 29, 2025
  • The options were originally granted on June 30, 2015 with a 10-year term

This Form 4 filing represents a standard options exercise by an insider before expiration. The transaction timing appears to be driven by the approaching expiration date rather than any specific market outlook. The exercise increases McPeak's direct equity stake in the company, potentially indicating confidence in the company's long-term prospects.

Il direttore di Research Solutions (RSSS), Merrill A. McPeak, ha esercitato opzioni su azioni e acquisito titoli il 18 giugno 2025. Dettagli principali della transazione:

  • Ha esercitato 75.000 opzioni su azioni a un prezzo di esercizio di 1,10 $ per azione
  • Dopo la transazione, McPeak possiede direttamente 409.608 azioni
  • Le opzioni esercitate erano in scadenza il 29 giugno 2025
  • Le opzioni erano state originariamente concesse il 30 giugno 2015 con una durata di 10 anni

La presentazione di questo modulo 4 rappresenta un esercizio standard di opzioni da parte di un insider prima della scadenza. Il tempismo della transazione sembra essere motivato dalla prossima scadenza piuttosto che da una specifica previsione di mercato. L'esercizio aumenta la partecipazione azionaria diretta di McPeak nella società, indicando potenzialmente fiducia nelle prospettive a lungo termine dell'azienda.

El director de Research Solutions (RSSS), Merrill A. McPeak, ejerció opciones sobre acciones y adquirió participaciones el 18 de junio de 2025. Detalles clave de la transacción:

  • Ejerció 75.000 opciones sobre acciones a un precio de ejercicio de $1.10 por acción
  • Tras la transacción, McPeak posee directamente 409.608 acciones
  • Las opciones ejercidas estaban programadas para expirar el 29 de junio de 2025
  • Las opciones fueron originalmente otorgadas el 30 de junio de 2015 con un plazo de 10 años

Esta presentación del Formulario 4 representa un ejercicio estándar de opciones por parte de un insider antes de la expiración. El momento de la transacción parece estar motivado por la proximidad de la fecha de vencimiento más que por una perspectiva de mercado específica. El ejercicio incrementa la participación accionaria directa de McPeak en la empresa, lo que podría indicar confianza en las perspectivas a largo plazo de la compañía.

Research Solutions(RSSS) 이사 Merrill A. McPeak가 2025년 6월 18일 주식매수선택권을 행사하여 주식을 취득했습니다. 주요 거래 내용은 다음과 같습니다:

  • 75,000주의 주식매수선택권을 주당 $1.10 행사가격으로 행사함
  • 거래 후 McPeak는 직접 409,608주를 보유하게 됨
  • 행사한 옵션은 2025년 6월 29일 만료 예정이었음
  • 옵션은 2015년 6월 30일에 10년 만기로 부여됨

이번 Form 4 제출은 내부자가 만료 전에 표준적으로 옵션을 행사한 사례입니다. 거래 시점은 특정 시장 전망보다는 만료일이 다가옴에 따른 것으로 보입니다. 이번 행사는 McPeak의 회사 지분을 직접 증가시켜 회사의 장기적인 전망에 대한 신뢰를 나타낼 수 있습니다.

Le directeur de Research Solutions (RSSS), Merrill A. McPeak, a exercé des options d'achat d'actions et acquis des titres le 18 juin 2025. Détails clés de la transaction :

  • Exercice de 75 000 options d'achat au prix d'exercice de 1,10 $ par action
  • Après la transaction, McPeak détient directement 409 608 actions
  • Les options exercées devaient expirer le 29 juin 2025
  • Les options avaient été initialement accordées le 30 juin 2015 pour une durée de 10 ans

Ce dépôt du formulaire 4 représente un exercice standard d'options par un initié avant expiration. Le timing de la transaction semble motivé par la date d'expiration imminente plutôt que par une perspective de marché spécifique. L'exercice augmente la participation directe de McPeak dans la société, indiquant potentiellement une confiance dans les perspectives à long terme de l'entreprise.

Der Direktor von Research Solutions (RSSS), Merrill A. McPeak, hat am 18. Juni 2025 Aktienoptionen ausgeübt und Aktien erworben. Wichtige Transaktionsdetails:

  • Ausübung von 75.000 Aktienoptionen zu einem Ausübungspreis von 1,10 $ pro Aktie
  • Nach der Transaktion besitzt McPeak direkt 409.608 Aktien
  • Die ausgeübten Optionen hätten am 29. Juni 2025 ablaufen sollen
  • Die Optionen wurden ursprünglich am 30. Juni 2015 mit einer Laufzeit von 10 Jahren gewährt

Diese Form 4-Meldung stellt eine standardmäßige Ausübung von Optionen durch einen Insider vor Ablauf dar. Der Zeitpunkt der Transaktion scheint eher durch das bevorstehende Ablaufdatum als durch eine spezifische Markterwartung bestimmt zu sein. Die Ausübung erhöht McPeaks direkten Aktienanteil am Unternehmen und könnte auf Vertrauen in die langfristigen Aussichten des Unternehmens hinweisen.

Positive
  • None.
Negative
  • None.

Il direttore di Research Solutions (RSSS), Merrill A. McPeak, ha esercitato opzioni su azioni e acquisito titoli il 18 giugno 2025. Dettagli principali della transazione:

  • Ha esercitato 75.000 opzioni su azioni a un prezzo di esercizio di 1,10 $ per azione
  • Dopo la transazione, McPeak possiede direttamente 409.608 azioni
  • Le opzioni esercitate erano in scadenza il 29 giugno 2025
  • Le opzioni erano state originariamente concesse il 30 giugno 2015 con una durata di 10 anni

La presentazione di questo modulo 4 rappresenta un esercizio standard di opzioni da parte di un insider prima della scadenza. Il tempismo della transazione sembra essere motivato dalla prossima scadenza piuttosto che da una specifica previsione di mercato. L'esercizio aumenta la partecipazione azionaria diretta di McPeak nella società, indicando potenzialmente fiducia nelle prospettive a lungo termine dell'azienda.

El director de Research Solutions (RSSS), Merrill A. McPeak, ejerció opciones sobre acciones y adquirió participaciones el 18 de junio de 2025. Detalles clave de la transacción:

  • Ejerció 75.000 opciones sobre acciones a un precio de ejercicio de $1.10 por acción
  • Tras la transacción, McPeak posee directamente 409.608 acciones
  • Las opciones ejercidas estaban programadas para expirar el 29 de junio de 2025
  • Las opciones fueron originalmente otorgadas el 30 de junio de 2015 con un plazo de 10 años

Esta presentación del Formulario 4 representa un ejercicio estándar de opciones por parte de un insider antes de la expiración. El momento de la transacción parece estar motivado por la proximidad de la fecha de vencimiento más que por una perspectiva de mercado específica. El ejercicio incrementa la participación accionaria directa de McPeak en la empresa, lo que podría indicar confianza en las perspectivas a largo plazo de la compañía.

Research Solutions(RSSS) 이사 Merrill A. McPeak가 2025년 6월 18일 주식매수선택권을 행사하여 주식을 취득했습니다. 주요 거래 내용은 다음과 같습니다:

  • 75,000주의 주식매수선택권을 주당 $1.10 행사가격으로 행사함
  • 거래 후 McPeak는 직접 409,608주를 보유하게 됨
  • 행사한 옵션은 2025년 6월 29일 만료 예정이었음
  • 옵션은 2015년 6월 30일에 10년 만기로 부여됨

이번 Form 4 제출은 내부자가 만료 전에 표준적으로 옵션을 행사한 사례입니다. 거래 시점은 특정 시장 전망보다는 만료일이 다가옴에 따른 것으로 보입니다. 이번 행사는 McPeak의 회사 지분을 직접 증가시켜 회사의 장기적인 전망에 대한 신뢰를 나타낼 수 있습니다.

Le directeur de Research Solutions (RSSS), Merrill A. McPeak, a exercé des options d'achat d'actions et acquis des titres le 18 juin 2025. Détails clés de la transaction :

  • Exercice de 75 000 options d'achat au prix d'exercice de 1,10 $ par action
  • Après la transaction, McPeak détient directement 409 608 actions
  • Les options exercées devaient expirer le 29 juin 2025
  • Les options avaient été initialement accordées le 30 juin 2015 pour une durée de 10 ans

Ce dépôt du formulaire 4 représente un exercice standard d'options par un initié avant expiration. Le timing de la transaction semble motivé par la date d'expiration imminente plutôt que par une perspective de marché spécifique. L'exercice augmente la participation directe de McPeak dans la société, indiquant potentiellement une confiance dans les perspectives à long terme de l'entreprise.

Der Direktor von Research Solutions (RSSS), Merrill A. McPeak, hat am 18. Juni 2025 Aktienoptionen ausgeübt und Aktien erworben. Wichtige Transaktionsdetails:

  • Ausübung von 75.000 Aktienoptionen zu einem Ausübungspreis von 1,10 $ pro Aktie
  • Nach der Transaktion besitzt McPeak direkt 409.608 Aktien
  • Die ausgeübten Optionen hätten am 29. Juni 2025 ablaufen sollen
  • Die Optionen wurden ursprünglich am 30. Juni 2015 mit einer Laufzeit von 10 Jahren gewährt

Diese Form 4-Meldung stellt eine standardmäßige Ausübung von Optionen durch einen Insider vor Ablauf dar. Der Zeitpunkt der Transaktion scheint eher durch das bevorstehende Ablaufdatum als durch eine spezifische Markterwartung bestimmt zu sein. Die Ausübung erhöht McPeaks direkten Aktienanteil am Unternehmen und könnte auf Vertrauen in die langfristigen Aussichten des Unternehmens hinweisen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCPEAK MERRILL A

(Last) (First) (Middle)
C/O RESEARCH SOLUTIONS, INC.

(Street)

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Research Solutions, Inc. [ RSSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 M 75,000 A $1.1 409,608 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase common stock $1.1 06/18/2025 M 75,000 06/30/2015 06/29/2025 Common Stock 75,000 $0 0 D
Explanation of Responses:
/s/ William Nurthen, Attorney-in-Fact 06/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction occurred at RSSS on June 18, 2025?

Director Merrill A. McPeak exercised 75,000 stock options at a price of $1.10 per share, converting them to common stock. Following this transaction, McPeak owned 409,608 shares of RSSS common stock directly.

How many RSSS shares does Director McPeak own after the June 2025 transaction?

Following the stock option exercise on June 18, 2025, Director Merrill A. McPeak owned 409,608 shares of RSSS common stock directly.

What was the exercise price of RSSS stock options exercised by Director McPeak?

The stock options were exercised at a price of $1.10 per share. These options were set to expire on June 29, 2025, and had been exercisable since June 30, 2015.

Did RSSS Director McPeak sell any shares in this Form 4 filing?

No, Director McPeak did not sell any shares in this transaction. The Form 4 shows only the acquisition of shares through the exercise of stock options, converting 75,000 options into an equal number of common shares.
Research Solutions Inc

NASDAQ:RSSS

RSSS Rankings

RSSS Latest News

RSSS Latest SEC Filings

RSSS Stock Data

91.86M
26.69M
17.61%
46.03%
0.13%
Software - Application
Services-business Services, Nec
Link
United States
HENDERSON